Efficacy of Ericksonian Hypnosis in the Management of Chronic Pain Related to Parkinson's Disease

Last updated: December 4, 2025
Sponsor: University Hospital, Lille
Overall Status: Completed

Phase

N/A

Condition

Chronic Pain

Pain

Treatment

Erickson hypnosis

Clinical Study ID

NCT04259203
2018-51
2019-A00539-48
  • Ages 18-80
  • All Genders

Study Summary

This study evaluates the efficacity of Erickson hypnosis in the treatment of chronic pain in patients with Parkinson's disease. Half of participants will follow a 2-month Erickson hypnosis protocole, while the other half will benefit from the usual care.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Men or women

  • 18 to 80 years old

  • idiopathic Parkinson's disease

  • without neurological co-morbidity

  • Suffering from chronic pain (for at least 3 months), related to Parkinson's disease

  • Having a pain intensity of at least 30 mm on the VAS (average intensity over theprevious week) for Parkinson's disease-related pain

  • antiparkinsonian, analgesic and psychotropic treatments stable for 1-month

  • having a health insurance

  • signed informed consent form

Exclusion

Exclusion Criteria:

  • Patient with a neurological condition other than Parkinson's disease or with anatypical Parkinson's syndrome

  • Early untreated patient

  • Patient with acute intercurrent pain

  • Patient whose pain is mainly attributable to another pathology (rheumatoidarthritis, spondyloarthritis ankylosing, diabetic neuropathy, cancer, etc.)

  • Patient with cognitive impairment objectified by a score at the Montreal CognitiveAssessment (MoCA) <24

  • Patient with hallucinations and/or psychosis (MDS-UPDRS 1.2> 1)

  • Patient with a apathy (MDS-UPDRS 1.5> 1)

  • Patient with disabling dyskinesia (MDS-UPDRS) 4.1 AND 4.2> 1)

  • Patient under the protection of adults

  • Pregnant or lactating woman

Study Design

Total Participants: 33
Treatment Group(s): 1
Primary Treatment: Erickson hypnosis
Phase:
Study Start date:
August 08, 2020
Estimated Completion Date:
August 16, 2024

Study Description

A large proportion of patients with Parkinson's disease suffer of chronic pain directly related to the disease. The management of painful symptoms is difficult and currently, there is no commonly admitted guidelines.

Several studies have shown the efficacy of Erickson hypnosis to reduce the perception of chronic pain in different conditions. This efficacy has never been tested in Parkinson's disease.

The objective of this study is to assess the efficacy of Erickson hypnosis protocol, compared to usual care, for the management of Parkinson's disease-related chronic pain.

The study team assume that Erickson hypnosis will be more efficient than usual care to reduce perceived chronic pain. They also assume that regular practice of autohypnosis will contribute to long-term efficacy.

Connect with a study center

  • Chu Cote de Nacre

    Caen,
    France

    Site Not Available

  • Chu Cote de Nacre

    Caen 3029241,
    France

    Site Not Available

  • Hôpital Roger Salengro, CHRU de Lille

    Lille, 59800
    France

    Site Not Available

  • Hôpital Roger Salengro, CHRU de Lille

    Lille 2998324, 59800
    France

    Site Not Available

  • Hopital Charles Nicolle Chu Rouen

    Rouen,
    France

    Site Not Available

  • Hopital Charles Nicolle Chu Rouen

    Rouen 2982652,
    France

    Site Not Available

  • Hopital Purpan Chu Toulouse

    Toulouse, 31300
    France

    Site Not Available

  • Hopital Purpan Chu Toulouse

    Toulouse 2972315, 31300
    France

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.